| European Case Law Identifier: | ECLI:EP:BA:2016:T260212.20161013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 13 October 2016 | ||||||||
| Case number: | T 2602/12 | ||||||||
| Application number: | 04741077.4 | ||||||||
| IPC class: | A61L 27/54 A61L 27/26 G02B 1/04 G02C 7/04 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | ANTIMICROBIAL MEDICAL DEVICES | ||||||||
| Applicant name: | Novartis AG | ||||||||
| Opponent name: | Johnson & Johnson Vision Care, Inc. | ||||||||
| Board: | 3.3.10 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of main request (yes) - restriction of granted claim 1 to subject-matter for which no negative decision has been issued by the Opposition Division is legitimate behaviour of losing party, no abuse of procedure Sufficiency of disclosure (yes) Sufficiency of disclosure - sufficient guidance in patent in suit to make dispersions with the required stability Inventive step (yes) Inventive step - argument raised for first time at oral proceedings against embodiment of invention never previously attacked under Article 56 EPC not admitted; Board sees no reason to examine of its own motion |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t122602eu1.html
Date retrieved: 17 May 2021